Sarah Cannon, SCRI Oncology Partners — Nashville, Tennessee

Sarah Cannon, SCRI Oncology Partners is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon, SCRI Oncology Partners has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Malignant Solid Neoplasm, RAS Mutation, Lung Cancer.

Sponsors: RasCal Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

• Vanderbilt University Medical Center Diagnostic Lab- Site Number : 840049
• 10-20 Vanderbilt University Medical Center
• Monroe Carell Jr Children's Hospital at Vanderbilt
• Vanderbilt University Medical Center Clinical Research Center
• Vanderbilt University Medical Center /ID# 204231
• Vanderbilt University Medical Center-GCRC
• GI Clinical Research; Vanderbilt University Medical Center
• Vanderbilt University Medical Center /ID# 164607
• The Children's Hospital at TriStar Centennial Medical Center
• Vanderbilt University Medical Center; Multiple Sclerosis Center
• Monroe Carrell Jr Children's Hospital at Vanderbilt
• Vanderbilt University ASAP Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon, SCRI Oncology Partners?

Sarah Cannon, SCRI Oncology Partners has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon, SCRI Oncology Partners conducted?

Sarah Cannon, SCRI Oncology Partners has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Malignant Solid Neoplasm, RAS Mutation, Lung Cancer.

Is Sarah Cannon, SCRI Oncology Partners accredited by Crixeo Clinical Trials?

Sarah Cannon, SCRI Oncology Partners has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon, SCRI Oncology Partners?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.